21 /100
LOW RISK
Score updated May 30, 2026

BRNS — Barinthus Biotherapeutics plc Dilution Risk Tracker

Track BRNS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BRNS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.62 below $1 exchange minimum
🔔 Track BRNS — Get forecast alerts →

💹 Market Data

Market Cap$27.81M
Shares Outstanding40.85M
Float27.26M
Cash$65.86M
Debt$159.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 13.8% shares (2025Q4 vs prior)
13 institutional holders · 7.90M shares
#1 M&G PLC 5.20M shares
#2 HSG Holding Ltd 1.42M shares
#3 DC Funds, LP 642.2K shares
+ 10 more holders Sign up free to view →

📉 Short Interest

Short Interest14.3K
Days to Cover1.0
% of Float0.1%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2020
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track BRNS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BRNS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for BRNS
📊 BRNS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BRNS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.